NDC 63323-739-11 - Famotidine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-739
- Requested NDC
- 63323-739-11
- Package NDCs from labels
- 63323-739-11, 63323-739-12, 63323-739-41, 63323-739-16
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2022-11-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Famotidine - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2022-11-08 | HUMAN PRESCRIPTION DRUG LABEL |
| FAMOTIDINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2022-10-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Famotidine - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2021-07-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-739-16 | Famotidine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-739-41 | Famotidine | 2 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 2 | 7 | |
| 63323-739-11 | Famotidine | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 6 | |
| 63323-739-12 | Famotidine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-739 | FAMOTIDINE (FAMOTIDINE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 2 package rows | 20210813_ce533636-cc9b-45d0-87a6-5390377ff28a.zip |
| 63323-739 | FAMOTIDINE (FAMOTIDINE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 6 | Current NDC, Legacy NDC, 2 package rows | 20221110_aeb27cea-1ff7-4a6e-93f1-d4c4dac5faa7.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-739-12 | ML - Milliliter | 63323-739 | 74793723-25b7-47ca-85fd-55f10754f442 | 1 | 2012-07-24 |
| 63323-739-16 | ML - Milliliter | 63323-739 | dea01bc8-4698-4e8a-b7fc-dcae793097e9 | 1 | 2015-09-10 |
| 63323-739-41 | ML - Milliliter | 63323-739 | 7deeac44-e43c-40d5-b6b8-93ccf5eb8133 | 1 | 2024-08-12 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FAMOTIDINE | ACTIVE INGREDIENT | 5QZO15J2Z8 | FAMOTIDINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| FAMOTIDINE | ACTIVE INGREDIENT | 5QZO15J2Z8 | FAMOTIDINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| FAMOTIDINE | ACTIVE MOIETY | 5QZO15J2Z8 | FAMOTIDINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| FAMOTIDINE | ACTIVE MOIETY | 5QZO15J2Z8 | FAMOTIDINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| ASPARTIC ACID | INACTIVE INGREDIENT | 30KYC7MIAI | FAMOTIDINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| ASPARTIC ACID | INACTIVE INGREDIENT | 30KYC7MIAI | FAMOTIDINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | FAMOTIDINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Famotidine | FAMOTIDINE | REMEDYREPACK INC. | 669fbd46-cae5-4477-884e-8eca893d2e05 | 2026-09-09 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| COMPLETE ACID REDUCER | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | b023cd92-eabb-474b-9b5a-4b46cf48256b | 2026-09-08 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Aurohealth LLC | 5b161f25-c578-4ff4-a931-ff3a1e681c50 | 2026-09-04 | Warnings | 5QZO15J2Z8 |
| ACID REDUCER | FAMOTIDINE | Amazon.com Services LLC | d5823283-aa97-451e-ba0d-69f0e79c8514 | 2026-08-31 | Warnings | 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | REMEDYREPACK INC. | 9c5dce17-1865-4aa6-89f6-24dd55b5f06c | 2026-08-27 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| KUGIG ALOE FOAMING INTIMATE WASH | INTIMATE CLEANSING FOAM | Hong Kong KangXing Centennial Management Limited | 59f4d398-1186-a168-e063-6294a90ab44b | 2026-08-26 | Warnings | 059QF0KO0R |
| Pepcid Complete Dual Action Berry Flavor | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | Jones Healthcare Group - Packaging Services, Inc | fff07b68-02ca-438e-8d53-5b4edf5eefc5 | 2026-08-25 | Warnings | 5QZO15J2Z8 |
| Sterile Water | WATER | REMEDYREPACK INC. | 5dd5d148-6e23-41de-bff5-551b2aea9598 | 2026-08-24 | Warnings, Adverse reactions | 059QF0KO0R |
| Famotidine | FAMOTIDINE | PD-Rx Pharmaceuticals, Inc. | 599642c8-51cd-4220-e063-6394a90a5e20 | 2026-08-24 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Major Pharmaceuticals | 3e6d167f-91e4-4122-911d-d3da66386f44 | 2026-08-20 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| TrophAmine | ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE HYDROCHLORIDE, HISTIDINE, TYROSINE, N-ACETYL-TYROSINE, ALANINE, ARGININE, PROLINE, SERINE, GLYCINE, ASPARTIC ACID, GLUTAMIC ACID, AND TAURINE | B. Braun Medical Inc. | cb6d23ff-3ec5-445a-acbe-f88fd57949bf | 2026-08-19 | Warnings, Adverse reactions | 30KYC7MIAI |
| BM BM63 DROPS | CEANOTHUS, KALI ARSEN, KALI MUR, SELENIUM, THALLIUM, WIESBADEN | BM Private Limited | 59006d82-610a-2e08-e063-6394a90af1ed | 2026-08-14 | Warnings | 059QF0KO0R |
| Famotidine | FAMOTIDINE | Preferred Pharmaceuticals Inc. | cd95271c-cf39-47fb-97a6-f6ee1e619e4a | 2026-08-12 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| heartburn prevention | FAMOTIDINE | Kroger Company | c97851ef-7b49-4f6c-b165-147555db101a | 2026-08-11 | Warnings | 5QZO15J2Z8 |
| Sterile Water | WATER | Cardinal Health 107, LLC | 48d75a7c-8329-48a8-bea0-a8c144ddf637 | 2026-08-07 | Warnings, Adverse reactions | 059QF0KO0R |
| ACID REDUCER | FAMOTIDINE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | f347f870-1da4-4a77-8c20-63b703d24071 | 2026-08-05 | Warnings | 5QZO15J2Z8 |
| ACID REDUCER | FAMOTIDINE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 7e5f9492-1d58-47a3-aac6-c41c81b348d5 | 2026-08-03 | Warnings | 5QZO15J2Z8 |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | Doc Rx | 9f5de6af-e555-4efd-a3ed-b72c34c051b6 | 2026-08-01 | Boxed warning, Warnings, Adverse reactions | 5QZO15J2Z8 |
| Garzulys | INSULIN ASPART-FSAN | Meitheal Pharmaceuticals Inc. | 30c64769-d2f7-4604-ac9e-2a6bc09506c9 | 2026-07-31 | Warnings, Adverse reactions | 059QF0KO0R |
| FAMOTIDINE | FAMOTIDINE | PD-Rx Pharmaceuticals, Inc. | a0f38398-4d34-4ecc-8a6a-37732adaaad3 | 2026-07-30 | Warnings, Adverse reactions | 5QZO15J2Z8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.